NCT00344370

Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

Double-Blind, Follow-On Study of Pitavastatin (4 mg) Versus Atorvastatin (20 mg and 40 mg), With a Single-Blind Extension of Treatment, in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 214 (actual)
• Sponsor: Kowa Research Europe · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This is a sixteen-week double-blind active-controlled follow-on and 28-week single-blind extension study for patients who participated in study NK-104-305.

Conditions

• Type II Diabetes Mellitus
• Dyslipidemia

Interventions

Type	Name	Description
DRUG	Pitavastatin	Pitavastatin 4 mg QD
DRUG	Atorvastatin	Atorvastatin 40 mg

Timeline

• Start date: 2006-08-01
• Primary completion: 2008-04-01
• Completion: 2008-04-01
• First posted: 2006-06-26
• Last updated: 2010-02-02
• Results posted: 2010-01-18

Locations

35 sites across 6 countries: Denmark, Germany, India, Netherlands, Poland, United Kingdom